These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor. Li X, Singh SM, Labrie F. J Med Chem; 1995 Mar 31; 38(7):1158-73. PubMed ID: 7707319 [Abstract] [Full Text] [Related]
3. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. Issa S, Schnabel D, Feix M, Wolf L, Schaefer HE, Russell DW, Schweikert HU. J Clin Endocrinol Metab; 2002 Dec 31; 87(12):5401-7. PubMed ID: 12466325 [Abstract] [Full Text] [Related]
4. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor. Liang T, Heiss CE, Cheung AH, Reynolds GF, Rasmusson GH. J Biol Chem; 1984 Jan 25; 259(2):734-9. PubMed ID: 6693392 [Abstract] [Full Text] [Related]
5. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts. Berkovitz GD, Brown TR, Migeon CJ. J Androl; 1984 Jan 25; 5(3):171-5. PubMed ID: 6746410 [Abstract] [Full Text] [Related]
6. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro]. Tolman RL, Sahoo SP, Bakshi RK, Gratale D, Patel G, Patel S, Toney J, Chang B, Harris GS. J Steroid Biochem Mol Biol; 1997 Mar 25; 60(5-6):303-9. PubMed ID: 9219921 [Abstract] [Full Text] [Related]
7. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one. Leshin M, Wilson JD. J Steroid Biochem; 1982 Sep 25; 17(3):245-50. PubMed ID: 6957692 [Abstract] [Full Text] [Related]
8. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2. Guarna A, Belle C, Machetti F, Occhiato EG, Payne AH, Cassiani C, Comerci A, Danza G, De Bellis A, Dini S, Marrucci A, Serio M. J Med Chem; 1997 Mar 28; 40(7):1112-29. PubMed ID: 9089333 [Abstract] [Full Text] [Related]
9. The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque. Rittmaster RS, Uno H, Povar ML, Mellin TN, Loriaux DL. J Clin Endocrinol Metab; 1987 Jul 28; 65(1):188-93. PubMed ID: 3584395 [Abstract] [Full Text] [Related]
10. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. Diani AR, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Schostarez HJ, Brunden MN, Buhl AE. J Clin Endocrinol Metab; 1992 Feb 28; 74(2):345-50. PubMed ID: 1309834 [Abstract] [Full Text] [Related]
11. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity. Orlowski J, Clark AF. Prostate; 1988 Feb 28; 13(4):289-97. PubMed ID: 3217276 [Abstract] [Full Text] [Related]
12. Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding. Rasmusson GH, Reynolds GF, Steinberg NG, Walton E, Patel GF, Liang T, Cascieri MA, Cheung AH, Brooks JR, Berman C. J Med Chem; 1986 Nov 28; 29(11):2298-315. PubMed ID: 3783591 [Abstract] [Full Text] [Related]
14. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. J Invest Dermatol; 1995 Aug 28; 105(2):209-14. PubMed ID: 7636302 [Abstract] [Full Text] [Related]
15. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Hirsch KS, Jones CD, Audia JE, Andersson S, McQuaid L, Stamm NB, Neubauer BL, Pennington P, Toomey RE, Russell DW. Proc Natl Acad Sci U S A; 1993 Jun 01; 90(11):5277-81. PubMed ID: 8389478 [Abstract] [Full Text] [Related]
16. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid. Kadohama N, Karr JP, Murphy GP, Sandberg AA. Cancer Res; 1984 Nov 01; 44(11):4947-54. PubMed ID: 6488158 [Abstract] [Full Text] [Related]
18. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells. Délos S, Iehlé C, Martin PM, Raynaud JP. J Steroid Biochem Mol Biol; 1994 Mar 01; 48(4):347-52. PubMed ID: 8142312 [Abstract] [Full Text] [Related]
19. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. Délos S, Carsol JL, Ghazarossian E, Raynaud JP, Martin PM. J Steroid Biochem Mol Biol; 1995 Dec 01; 55(3-4):375-83. PubMed ID: 8541234 [Abstract] [Full Text] [Related]
20. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors. Toomey RE, Goode RL, Petrow V, Neubauer BL. Prostate; 1991 Dec 01; 19(1):63-72. PubMed ID: 1876537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]